info:eu-repo/semantics/conferenceObject
Cáncer de mama y disfunción sexual femenina: análisis en una muestra de mujeres peruanas adultas
Fecha
2019-10-13Autor
Pasapera-Rivera, Manuel
Zeta-Solis, Ludwing
Mendoza-de-Lama, Gastón
Mezones Holguin, Edward
Institución
Resumen
Introduction: Sexuality is a complex area in women,
especially in those who have been diagnosed with
breast cancer (BC).
Objective: To evaluate whether there is an association
between breast cancer (BC) and sexual dysfunction
(SD) in adult women in a national reference
hospital of Social Security in Peru.
Method and sample: We carried out an analysis in
167 women under 60 years of age, which were divided
into two groups: with BC (after mastectomy and without
mastectomy), and without cancer. We used the validation
of the Spanish version of the Female Sexual
Dysfunction Index. We made a comparison among
women with BC and without cancer (A). Additionally,
we carried out two exploratory comparisons: among
women with BC after mastectomy and without mastectomy
(B); and another among women without BC, with
BC after mastectomy, and with BC without mastectomy (C). We estimated crude prevalence ratios (cPR) and
adjusted prevalence ratios (aPR) with 95% CI using
generalized lineal Poisson regression models with a
non-parametric bias-corrected and accelerated boostrap.
Results: The frequencies of SD were 95,7%; 43,8%
and 35,1% in women with BC after mastectomy; with
BC without undergoing mastectomy and without cancer,
respectively. In A, it was observed that women
with BC presented a higher probability of SD than
those without cancer (cPR:1.86; CI95%:1,27–2,72/
aPR:1,51; CI95%:1,06–2,15). In B, it was evidenced
that, among women with BC, those after mastectomy
had a higher probability of SD (cPR:2,19; CI95%:
1,63–2,92/ aPR:1,62; CI95%: 1,26–2,08). In C, a higher
probability of SD was identified in women with BC
after mastectomy versus women without cancer (cPR
2,73; CI 95%: 1,88–3,94/ aPR:1,93; CI 95%: 1,32–2,80). Conclusion and recommendation: The frequency of
SD is higher in women with breast cancer and, in this
group, the probability is higher in women with mastectomy
antecedents. In this group of women, the sexual
sphere should be explored in the clinical practice.